A New FDA Approval Brings New Psychiatric Risks
The Carlat Psychiatry Podcast
00:00
Risks and Warnings Associated with New Psychiatric Treatments
This chapter explores the risks tied to a new FDA-approved medication and the concerns surrounding the 'Holy Trinity' medication combination. It highlights the exclusions of certain patient groups in trials, particularly those with psychiatric issues, and addresses potential adverse effects such as mania in bipolar disorder patients.
Transcript
Play full episode
